Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024

Allurion Technologies, Inc. (NYSE:ALUR) ("Allurion" or the "Company"), a company dedicated to ending obesity, today announced that it will report financial results for the second quarter 2024 on Tuesday, August 13,

BusinesswireJul 16 16:05 ET

Express News | Allurion Technologies Shares Are Trading Lower After the Company Priced a $20 Million Public Offering

BenzingaJun 28 11:34 ET

Allurion Technologies: Proceeds to Fund Clinical Trials, Comml Sales and R&D >ALUR

Allurion Technologies: Proceeds to Fund Clinical Trials, Comml Sales and R&D >ALUR

Dow JonesJun 28 09:10 ET

Allurion Technologies to Place 14.4M Shares at a Public Offering Price of $1.20 Per Share for Gross Proceeds of $17.3M >ALUR

Allurion Technologies to Place 14.4M Shares at a Public Offering Price of $1.20 Per Share for Gross Proceeds of $17.3M >ALUR

Dow JonesJun 28 09:09 ET

Express News | Allurion Announces Pricing of $20 Million Public Offering and Concurrent Private Placement

ReutersJun 28 09:06 ET

Top Midday Decliners

CNS Pharmaceuticals (CNSP) shares plunged more than 37% amid heavy trading Wednesday after the company said it priced a registered direct offering and warrants at $2.45 per share. Over 1.3 million sha

MT NewswiresJun 26 13:48 ET